Differential activation of cytokine secretion in primary human colonic fibroblast/myofibroblast cultures

被引:60
作者
Rogler, G
Gelbmann, CM
Vogl, D
Brunner, M
Schölmerich, J
Falk, W
Andus, T
Brand, K
机构
[1] Univ Regensburg, Dept Internal Med 1, D-8400 Regensburg, Germany
[2] Tech Univ Munich, Inst Clin Chem & Pathobiochem, D-8000 Munich, Germany
关键词
IBD; myofibroblasts; NF-kappa B; IL-8; IL-6;
D O I
10.1080/003655201300051216
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Fibroblasts and myofibroblasts are known to secrete a wide spectrum of cytokines, but the individual spectrum is tissue-specific. We investigated the effect of cell activation on cytokine secretion of isolated human colonic fibroblasts/myofibroblasts from control patients and patients with mucosal inflammation. Methods: Primary cultures of human colonic submucosal fibroblasts/myofibroblasts were incubated with IL-1 alpha (100 U/ml), IL-1 beta (10 ng/ml), IL-10 (10 ng/ml), TNF (10 ng/ml), PMA (10 ng/ml), LPS (50 ng/ml), IL-4 (10 ng/ml), or a combination of EL-I and TNF. Secreted cytokines were determined by ELISA. NF-kappaB activation was demonstrated by electrophoretic mobility-shift assays (EMSA). Results: Incubation of colonic fibroblasts/myofibroblasts with IL-1, LPS, TNF and PMA induced secretion of IL-6, IL-8, M-CSF and GM-CSF. IL-8 and IL-6 secretion could be stimulated by IL-1 alpha, IL-1 beta, TNF, PMA and LPS within 6 h of incubation. IL-6 secretion was stimulated from 0.5 +/- 0.01 pg/h x mug fibroblast protein to 18.5 +/- 2.6 pg/h x mug fibroblast protein with IL-1 beta (P < 0.01). IL-8 secretion was stimulated from 1.0 <plus/minus> 0.1 pg/h x mug fibroblast protein to 41.1 +/- 3.6 pg/h x pg (P < 0.005). IL-4 and IL-10 did not change cytokine secretion significantly. No significant differences between cultures from normal and inflamed mucosa were observed. TNF and IL-1 induced NF-<kappa>B activation. ALLN, a proteasome and NF-kappaB activation inhibitor, reduced TNF-mediated IL-8, GM-CSF and M-CSF induction significantly, whereas induction of IL-6 secretion remained unchanged. Conclusion: Human colonic myofibroblasts can secrete large amounts of IL-6, IL-8, M-CSF and GM-CSF upon stimulation. The induction of IL-8, M-CSF and GM-CSF, but not of IL-6 secretion, is mediated mainly by NF-kappaB activation. The cytokine profile and the total amounts of cytokines released suggest that colonic myofibroblasts can play a role in leukocyte recruitment and during mucosal inflammation. They therefore have to be regarded as an important part of the mucosal immune system.
引用
收藏
页码:389 / 398
页数:10
相关论文
共 47 条
[1]   NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules [J].
Baeuerle, PA ;
Baichwal, VR .
ADVANCES IN IMMUNOLOGY, VOL 65, 1997, 65 :111-137
[2]   NF-kappa B: Ten years after [J].
Baeuerle, PA ;
Baltimore, D .
CELL, 1996, 87 (01) :13-20
[3]   THE INDUCIBLE TRANSCRIPTION ACTIVATOR NF-KAPPA-B - REGULATION BY DISTINCT PROTEIN SUBUNITS [J].
BAEUERLE, PA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (01) :63-80
[4]  
BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
[5]   I-KAPPA-B - A SPECIFIC INHIBITOR OF THE NF-KAPPA-B TRANSCRIPTION FACTOR [J].
BAEUERLE, PA ;
BALTIMORE, D .
SCIENCE, 1988, 242 (4878) :540-546
[6]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[7]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[8]   Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion [J].
Brand, K ;
Page, S ;
Rogler, G ;
Bartsch, A ;
Brandl, R ;
Knuechel, R ;
Page, M ;
Kaltschmidt, C ;
Baeuerle, PA ;
Neumeier, D .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (07) :1715-1722
[9]   Modulation of barrier function of small intestinal epithelial cells by lamina propria fibroblasts in response to lipopolysaccharide:: Possible role of TNFα in inducing barrier dysfunction [J].
Chakravortty, D ;
Kumar, KSN .
MICROBIOLOGY AND IMMUNOLOGY, 1999, 43 (06) :527-533
[10]  
CHENG Q, 1994, J BIOL CHEM, V269, P13551